SCHEMBL6096895

SCHEMBL6096895

O=C(c1cccc2cc[nH]c12)N1CCN(c2cccs2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 2/20 0.47
NPC1 O15118 1/20 0.47
POLB P06746 1/20 0.47
HPGD P15428 1/20 0.47
MAPK1 P28482 1/20 0.47
RAB9A P51151 1/20 0.47
KEAP1 Q14145 1/20 0.46
PDPK1 O15530 1/20 0.45
HCRTR1 O43613 1/20 0.44
HCRTR2 O43614 1/20 0.44
LMNA P02545 4/20 0.39
USP2 O75604 2/20 0.39
TSHR P16473 1/20 0.39
P2RX7 Q99572 1/20 0.38
BCHE P06276 1/20 0.38
GAA P10253 2/20 0.38
ALOX12 P18054 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6095091 0.81 HCRTR1 (0.45) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL6095813 0.81 MAPK14 (0.57) MAPTHCRTR2GAA
SCHEMBL8291050 0.81 KEAP1 (0.54) ALDH1A1KMT2AHPGDKEAP1PDPK1
SCHEMBL8295958 0.80 ALDH1A1 (0.64) ALDH1A1MEN1KMT2AMAPTMAPK1
SCHEMBL6093704 0.80 KEAP1 (0.45) ALDH1A1MEN1KMT2AMAPTNPC1
SCHEMBL6094758 0.79 ALDH1A1 (0.43) ALDH1A1MEN1KMT2AMAPTNPC1
SCHEMBL6094762 0.79 ALDH1A1 (0.43) ALDH1A1MEN1KMT2AMAPTNPC1
SCHEMBL8291046 0.78 ALDH1A1 (0.59) ALDH1A1MEN1KMT2AHPGDMAPK1
SCHEMBL2214668 0.78 KEAP1 (0.57) ALDH1A1MAPTNPC1POLBHPGD
SCHEMBL8296024 0.77 MAPK1 (0.65) ALDH1A1MEN1KMT2AMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7084143-B2 N-(indolecarbonyl) piperazine derivatives MERCK PATENT GMBH (DE) 2006-08-01 US claimed
US-6838461-B1 N-(indolcarbonyl-)piperazine derivatives MERCK PATENT GMBH (DE) 2005-01-04 US claimed
US-20050096330-A1 N-(indolecarbonyl) piperazine derivatives BOETTCHER HENNING (DE) 2005-05-05 US disclosed
CN-1364157-A N-(indolcarbonyl) piperazin derivatives MERCK PATENT GMBH (DE) 2002-08-14 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050096330-A1 N-(indolecarbonyl) piperazine derivatives HTR2A, HTR2B, HTR2C ALDH1A1 2239/4885MEN1 1162/4885KMT2A 904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.